FAST NEWS: Antengene Corporation Announces First Ever Revenue of $7.8 Million
The latest: Antengene Corp. Ltd. (6996.HK), a biopharmaceutical company, announced Thursday it expects revenue for the six months ended June 30 this year to range from 53 million yuan ($7.8…
RELATED ARTICLES
-
Akeso marks profit milestone with swift rights issue
9926.HK -
Kintor shares plunge after hair-loss drug flops in clinical trials
9939.HK
-
BeiGene still bleeding red ink despite blockbuster drug
BGNE.US 6160.HK 688235.SHG
